Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflammatory biomarker identification in knee joint fluid to support Allocetra-OTS development for knee osteoarthritis
MOH_2023-03-21_012450Phase 3Completed
- Sponsor
- דר אמיר אורון
- Start
- Feb 2023
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Allocetra in knee osteoarthritis (OA), sponsored by דר אמיר אורון. Primary endpoint: Inflammatory and cellular characterization of knee joint samples. Started Feb 2023; status: completed.
02
Drugs
Allocetra
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on MOH_2023-03-21_012450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-03-21_012450.